Literature DB >> 28500479

[Catheter ablation of persistent atrial fibrillation : Where do we go?]

C Lemeš1, K-H Kuck2, S Mathew2.   

Abstract

Despite the very promising initial results of clinical studies, catheter ablation of persistent atrial fibrillation (AF) remains a challenge in modern electrophysiology. On the basis of the hypothesized pathophysiological mechanisms, a variety of ablation strategies have been developed over the course of time. The current ablation strategies range from pulmonary vein isolation (PVI) alone as first-line therapy, through ablation of multiple linear lesions, ablation of complex fractionated atrial electrograms (CFAE), rotor ablation, isolation of fibrotic and scar tissue up to isolation of the left atrial appendage (LAA); however, it is unclear even to the present day whether these complex and time-consuming strategies actually improve the success rate of ablation therapy. In recent years it has reproducibly been shown that with these ablation techniques more than one procedure is often necessary in order to achieve a stable sinus rhythm and even then only limited satisfactory success rates can be expected. The only currently established ablation endpoint is PVI. The stringent treatment of risk factors, such as arterial hypertension and obesity is becoming a focus of interest as an additive concept to ablation.

Entities:  

Keywords:  Ablation strategies; Atrial fibrillation; Pulmonary vein isolation; Risk factors; Success rates

Mesh:

Year:  2017        PMID: 28500479     DOI: 10.1007/s00059-017-4566-1

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  33 in total

1.  Impact of Rotor Ablation in Nonparoxysmal Atrial Fibrillation Patients: Results From the Randomized OASIS Trial.

Authors:  Sanghamitra Mohanty; Carola Gianni; Prasant Mohanty; Philipp Halbfass; Tamara Metz; Chintan Trivedi; Thomas Deneke; Gery Tomassoni; Rong Bai; Amin Al-Ahmad; Shane Bailey; John David Burkhardt; G Joseph Gallinghouse; Rodney Horton; Patrick M Hranitzky; Javier E Sanchez; Luigi Di Biase; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2016-05-06       Impact factor: 24.094

2.  Box Isolation of Fibrotic Areas (BIFA): A Patient-Tailored Substrate Modification Approach for Ablation of Atrial Fibrillation.

Authors:  Hans Kottkamp; Jan Berg; Roderich Bender; Andreas Rieger; Doreen Schreiber
Journal:  J Cardiovasc Electrophysiol       Date:  2015-11-20

3.  Unexpectedly High Incidence of Stroke and Left Atrial Appendage Thrombus Formation After Electrical Isolation of the Left Atrial Appendage for the Treatment of Atrial Tachyarrhythmias.

Authors:  Andreas Rillig; Roland R Tilz; Tina Lin; Thomas Fink; Christian-H Heeger; Anita Arya; Andreas Metzner; Shibu Mathew; Erik Wissner; Hisaki Makimoto; Peter Wohlmuth; Karl-Heinz Kuck; Feifan Ouyang
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-05

Review 4.  Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review.

Authors:  Anthony G Brooks; Martin K Stiles; Julien Laborderie; Dennis H Lau; Pawel Kuklik; Nicholas J Shipp; Li-Fern Hsu; Prashanthan Sanders
Journal:  Heart Rhythm       Date:  2010-01-22       Impact factor: 6.343

5.  Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study.

Authors:  Rajeev K Pathak; Adrian Elliott; Melissa E Middeldorp; Megan Meredith; Abhinav B Mehta; Rajiv Mahajan; Jeroen M L Hendriks; Darragh Twomey; Jonathan M Kalman; Walter P Abhayaratna; Dennis H Lau; Prashanthan Sanders
Journal:  J Am Coll Cardiol       Date:  2015-06-22       Impact factor: 24.094

6.  Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY).

Authors:  Rajeev K Pathak; Melissa E Middeldorp; Megan Meredith; Abhinav B Mehta; Rajiv Mahajan; Christopher X Wong; Darragh Twomey; Adrian D Elliott; Jonathan M Kalman; Walter P Abhayaratna; Dennis H Lau; Prashanthan Sanders
Journal:  J Am Coll Cardiol       Date:  2015-03-16       Impact factor: 24.094

7.  Left atrial appendage: an underrecognized trigger site of atrial fibrillation.

Authors:  Luigi Di Biase; J David Burkhardt; Prasant Mohanty; Javier Sanchez; Sanghamitra Mohanty; Rodney Horton; G Joseph Gallinghouse; Shane M Bailey; Jason D Zagrodzky; Pasquale Santangeli; Steven Hao; Richard Hongo; Salwa Beheiry; Sakis Themistoclakis; Aldo Bonso; Antonio Rossillo; Andrea Corrado; Antonio Raviele; Amin Al-Ahmad; Paul Wang; Jennifer E Cummings; Robert A Schweikert; Gemma Pelargonio; Antonio Dello Russo; Michela Casella; Pietro Santarelli; William R Lewis; Andrea Natale
Journal:  Circulation       Date:  2010-07-06       Impact factor: 29.690

8.  Current ablation techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey.

Authors:  Nikolaos Dagres; Maria Grazia Bongiorni; Torben Bjerregaard Larsen; Antonio Hernandez-Madrid; Laurent Pison; Carina Blomström-Lundqvist
Journal:  Europace       Date:  2015-10       Impact factor: 5.214

9.  Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial-Part II (STAR AF II): design and rationale.

Authors:  Atul Verma; Prashanthan Sanders; Laurent Macle; Isabel Deisenhofer; Carlos A Morillo; Jian Chen; Chen-yang Jiang; Sabine Ernst; Roberto Mantovan
Journal:  Am Heart J       Date:  2012-07       Impact factor: 4.749

10.  First-line catheter ablation of paroxysmal atrial fibrillation: outcome of radiofrequency vs. cryoballoon pulmonary vein isolation.

Authors:  Florian Straube; Uwe Dorwarth; Sonia Ammar-Busch; Timo Peter; Georg Noelker; Thomas Massa; Malte Kuniss; Niels Christian Ewertsen; Kyoung Ryul Julian Chun; Juergen Tebbenjohanns; Roland Tilz; Karl Heinz Kuck; Taoufik Ouarrak; Jochen Senges; Ellen Hoffmann
Journal:  Europace       Date:  2015-10-25       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.